Molecular cytogenetic aberrations in autosomal dominant polycystic kidney disease tissue

被引:25
作者
Gogusev, J
Murakami, I
Doussau, M
Telvi, L
Stojkoski, A
Lesavre, P
Droz, D
机构
[1] Hop Necker Enfants Malad, INSERM, U507, F-75015 Paris, France
[2] Hop St Vincent de Paul, Lab Cytogenet, F-75674 Paris, France
[3] Hop St Louis, Serv Cent Anat Pathol, Paris, France
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷 / 02期
关键词
D O I
10.1097/01.ASN.0000046963.60910.63
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Autosomal dominant polycystic kidney disease (ADPKD) is a genetically heterogeneous disorder characterized by focal cyst formation from any part of the nephron. The molecular bases include germinal mutation of either PKD1 or PKD2 genes, enhanced expression of several protooncogenes, alteration of the TGF-alpha/EGF/EGF receptor (EGFR) axis, and disturbed regulation of proliferative/apoptosis pathways. To identify new locations of ADPKD related oncogenes and/or tumor suppressor genes (TSG), comparative genomic hybridization (CGH) and loss of heterozygosity (LOH) analyses were performed for a series of individual cysts (n = 24) from eight polycystic kidneys. By CGH, imbalances were detected predominantly on chromosomes 1p, 9q, 16p, 19, and 22q in all tissues. DNA copy number gain was seen on chromosomes 3q and 4q in five samples. The CGH data were supplemented by LOH analysis using 83 polymorphic microsatellite markers distributed along chromosomes 1, 9, 16, 19, and 22. The highest frequency of LOH was found on the 1p35-36 and 16p13.3 segments in cysts from seven samples. Allelic losses on 9q were detected in six, whereas deletions at 19p13 and 22q11 bands were observed in three polycystic kidneys. These results indicate that the deleted chromosomal regions may contain genes important in ADPKD initiation and progression.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 53 条
[1]   Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease [J].
Baboolal, K ;
Ravine, D ;
Daniels, J ;
Williams, N ;
Holmans, P ;
Coles, GA ;
Williams, JD .
KIDNEY INTERNATIONAL, 1997, 52 (03) :607-613
[2]  
BELLOTTO M, 1995, PHYS CHEM MINER, V22, P207, DOI 10.1007/BF00202253
[3]   Loss of heterozygosity in human ovarian cancer on chromosome 19q [J].
Bicher, A ;
Ault, K ;
Kimmelman, A ;
Gershenson, D ;
Reed, E ;
Liang, B .
GYNECOLOGIC ONCOLOGY, 1997, 66 (01) :36-40
[4]   Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis [J].
Brasier, JL ;
Henske, EP .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (02) :194-199
[5]   The genetics and physiology of polycystic kidney disease [J].
Calvet, JP ;
Grantham, JJ .
SEMINARS IN NEPHROLOGY, 2001, 21 (02) :107-123
[6]  
Canzian F, 1996, CANCER RES, V56, P3331
[7]   EVIDENCE FOR A 3RD GENETIC-LOCUS FOR AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE [J].
DAOUST, MC ;
REYNOLDS, DM ;
BICHET, DG ;
SOMLO, S .
GENOMICS, 1995, 25 (03) :733-736
[8]   A new protein containing an SH2 domain that inhibits JAK kinases [J].
Endo, TA ;
Masuhara, M ;
Yokouchi, M ;
Suzuki, R ;
Sakamoto, H ;
Mitsui, K ;
Matsumoto, A ;
Tanimura, S ;
Ohtsubo, M ;
Misawa, H ;
Miyazaki, T ;
Leonor, N ;
Taniguchi, T ;
Fujita, T ;
Kanakura, Y ;
Komiya, S ;
Yoshimura, A .
NATURE, 1997, 387 (6636) :921-924
[9]   Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer [J].
Froudarakis, ME ;
Sourvinos, G ;
Fournel, P ;
Bouros, D ;
Vergnon, JM ;
Spandidos, DA ;
Siafakas, NM .
CHEST, 1998, 113 (04) :1091-1094
[10]  
Furuta S, 2000, MED PEDIATR ONCOL, V35, P531, DOI 10.1002/1096-911X(20001201)35:6<531::AID-MPO6>3.0.CO